Gastrointestinal Cancer News & Features
Researchers have shown that a certain protein becomes overabundant in pancreatic neuroendocrine tumors, allowing them to thrive. They also found that pairing a synthetic compound with an existing drug provides a more effective anticancer punch than a single drug.
Four-year study found survival doubled for GI cancer patients who took low-dose pill each day.
Use of irreversible electroporation (IRE) doubles survival time for patients with locally advanced pancreatic cancer.
A nurse-led walk-and-eat intervention is feasible and effective to preserve functional walking capacity and nutritional status in patients with esophageal cancer undergoing neoadjuvant chemoradiotherapy.
New study data associates the resection of colorectal cancer (CRC) liver metastases with greater risk of postoperative mortality among elderly patients.
Gastrointestinal Cancer Clinical Trials
- Clinical Trial Shows Vaccine Clears Some Precancerous Cervical Lesions
- Late-Stage Lung Cancer Often Overtreated
- Patients With Multiple Myeloma Vulnerable to Financial Toxicity Due to Costly Treatments
- New Treatment Option May Increase Metastatic Lung Cancer Survival
- New Approach Tackles Hormone Therapy Resistance in Breast Cancer
- Initial Safety Report Finds Acceptable Safety With Ibrutinib for Asymptomatic, High-Risk CLL
- Primary Care Physicians May Be Key to Meeting the Growing Demand for Cancer Care
- Half-Match Donors May be the Perfect Match In Transplantation for Blood Cancers
- Gay, Bisexual Men Report Higher Rates of Skin Cancer Than Heterosexual Men
- Fukushima Radiation May Be Increasing Pediatric Thyroid Cancer Rates
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|